|
|
||||||||||||||
|
|
|||||||||||||||
RESEARCH PAPER |
1 Institute of Health Care Organization Administration, National Taiwan University, Taipei, Taiwan
2 Division of Health Policy Research, National Health Research Institutes, Taipei, Taiwan
Correspondence to:
Ming-Chin Yang
Institute of Health Care Organization Administration, National Taiwan University, Taipei, Taiwan; mcy{at}ha.mc.ntu.edu.tw
Objective: To estimate the smoking attributable medical expenditures and productivity loss of people aged 35 and over in Taiwan in 2001 from a societal viewpoint.
Methods: A prevalence based approach was used to estimate smoking attributable costs. Epidemiological parameters were obtained from two follow up studies and government statistics. Data on medical care utilisation and expenditure were extracted from the National Health Insurance claim data.
Results: Total smoking attributable medical expenditures (SAEs) amounted to US$397.6 million, which accounted for 6.8% of the total medical expenditures for people aged 35 and over. Mean annual medical expenditures per smoker was US$70 more than that of each non-smoker. Smoking attributable years of potential life lost (YPLL) totalled to 217 761 years for males and 15 462 years for females, and the corresponding productivity loss was US$1371 million for males and US$18.7 million for females.
Conclusion: Medical expenditures attributable to smoking accounted for 6.8% of the total medical expenditure of people aged 35 and over for the year 2001 in Taiwan. Corresponding YPLL and productivity loss also demand that actions be taken to fight cigarette smoking.
Abbreviations: ICD-9, International classification of diseases, 9th revision; NHI, National Health Insurance; RR, relative risk; SAD, smoking attributable deaths; SAE, smoking attributable medical expenditure; SAMMEC II, smoking attributable mortality, morbidity, and economic costs software, release II; SAPDC, smoking attributable cost of premature deaths; SAYPLL, smoking attributable years of potential life lost; SFA, smoking attributable fraction; YPLL, years of potential life lost
Keywords: medical care costs; premature death; Taiwan
This article has been cited by other articles:
![]() |
C.-W. Chung, J.-D. Wang, C.-F. Yu, and M.-C. Yang Lifetime medical expenditure and life expectancy lost attributable to smoking through major smoking related diseases in Taiwan Tob. Control, December 1, 2007; 16(6): 394 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ross, D. V. Trung, and V. X. Phu The costs of smoking in Vietnam: the case of inpatient care Tob. Control, December 1, 2007; 16(6): 405 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Neubauer, R. Welte, A. Beiche, H.-H. Koenig, K. Buesch, and R. Leidl Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison Tob. Control, December 1, 2006; 15(6): 464 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
H-Y Sung, L Wang, S Jin, T-W Hu, and Y Jiang Economic burden of smoking in China, 2000 Tob. Control, June 1, 2006; 15(suppl_1): i5 - i11. [Abstract] [Full Text] [PDF] |
||||
![]() |
C P Wen Facilitating the critical process in tobacco control Tob. Control, June 1, 2005; 14(suppl_1): i1 - i3. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |